Healthy life expectancy at record low for women in most deprived areas
The Covid-19 pandemic, with its increased levels of mortality, is continuing to have an impact on life expectancy estimates, according to the Office for National Statistics (ONS) which published the figures.
Females born between 2020 and 2022 in the most deprived areas of England were likely to spend just 65.1% of their lives in good health, compared with 81.5% in the least deprived areas, the ONS found.
The estimate for the most deprived areas is the lowest since the time series began in 2013-15, when it stood at 66.3%.
For males born in 2020-22, the proportion of life expected to be spent in good health was 70.4% for those in the most deprived areas and 84.5% for those in the least deprived.
The figure for males in the most deprived parts of England is broadly unchanged on recent years.
The gap in healthy life expectancy between females born in the most and least deprived areas has widened from 19.6 years in 2013-15 to 20.2 years in 2020-22, while for males it has grown from 18.7 to 19.1.
Greg Ceely, ONS head of population health monitoring, said: 'The pandemic led to increased mortality, the impact of which is seen in our life expectancy estimates.
'However, not everyone was impacted equally.
'The biggest decline in life expectancy was seen in the most deprived areas.
'Healthy life expectancy also declined, and in England and Wales women in the most deprived areas were expected to spend the lowest proportion of life in 'good' health – the smallest since our records began.'
Figures for Wales cannot be compared directly with England, due to different systems of measuring deprivation.
But the proportion of life that females born in 2020-22 in the most deprived areas of Wales are likely to spend in good health, 61.5%, is the lowest since those estimates began in 2013-15.
The equivalent figure for women born in the least deprived areas is 80.7%.
For males in Wales, the proportions were 70.2% for the most deprived areas and 83.6% for the least deprived.
Although the latest estimates represent a drop compared with the pre-pandemic period, this does not mean a baby born between 2020 and 2022 will necessarily go on to live a less healthy life.
Improvements in mortality rates in the future would lead to increases in life expectancy estimates, the ONS noted.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
7 hours ago
- Daily Mirror
Covid strain in the UK could cause new 'wave of infection'
The XFG strain of Covid, known as Stratus, has quickly become one of the most dominant variants in the UK. An expert has warned that a new variant of Covid could cause another 'wave of infection'. The XFG variants, which are also known as 'Stratus', have already become the most dominant variant in the UK. The most recent figures from the UK Health Security Agency (UKHSA) indicate that the XFG strain, known as Stratus, is swiftly proliferating across England, with the World Health Organisation (WHO) alerting to its "rapidly growing" presence worldwide. As of May, the Stratus variant constituted 10 per cent of Covid-19 cases in England. Presently, the XFG and its derivative, XFG.3, are responsible for approximately 40 per cent of infections, according to UKHSA statistics. In the period spanning May 26 to June 8, 28.9 per cent of cases were identified as the XFG. 3 variant, while 11.4 per cent were attributed to XFG. As reported by the Manchester Evening News, both belong to the Stratus family, with XFG being the original and XFG. 3 its offshoot. Dr Alex Allen, consultant epidemiologist at UKHSA, said: "It is normal for viruses to mutate and change over time. UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and COVID-19 surveillance reports. "Based on the available information so far, there is no evidence to suggest that the XFG and XFG.3 variants cause more severe disease than previous variants, or that the vaccines in current use will be less effective against them." This update follows closely on the heels of the WHO's disclosure of a new "more transmissible" variant named Nimbus, or NB. 1.8.1, which is also under observation. The latest figures indicate that the Nimbus strain of Covid is on a downward trend in the UK, now accounting for just 7.19 per cent of cases in England under classification NB. 1.8.1. The Stratus variant has surpassed Nimbus to become the most prevalent variant in England. Virologist Professor Lawrence Young of Warwick University revealed to MailOnline the worrying rise of the Stratus variant and its forms XFG and XFG. 3: "The increased competitiveness of XFG and XFG.3 is likely due to new spike mutations which make these variants more able to evade the immune response." He sounded an alarm over waning immunity among the public, as a result of declining uptake of the spring booster vaccination and receding Covid infection numbers recently. Prof Young warned: "This could lead to a new wave of infection but it's difficult to predict the extent of this wave." Expressing concerns about the behaviour of the Stratus variant to Cosmopolitan UK, Dr Kaywaan Khan, Harley Street GP and Founder of Hannah London Clinic, said: "Unlike other variants, Stratus has certain mutations in the spike protein which could help it evade antibodies developed from prior infections or vaccinations." Dr Khan described the Stratus strain as an offshoot of the Omicron variant, known for its high transmissibility and first detected in November 2021. As we look at the situation in May 2025, reports show that XFG constitutes roughly 25 per cent of the global Covid case count. Dr Khan remarked: "Despite this, it is important to mention that Stratus seems to be no worse than earlier Omicron variants in terms of illness, hospitalisations, or deaths." The World Health Organisation (WHO) has cautioned that the XFG strain is proliferating swiftly on a global scale. The organisation reported that cases surged within a month, from accounting for seven per cent of worldwide instances to reaching 23 per cent as of June 1. Nevertheless, WHO has evaluated the threat level of this variant as "low". It maintains that there is no current evidence indicating that XFG presents additional health risks relative to prior variants of the virus. Symptoms The most recent COVID-19 variants, frequently casually referred to as "Frankenstein" variants, usually present with symptoms akin to previous Omicron subvariants. Such symptoms commonly include upper respiratory tract problems such as fever, cough, sore throat, runny nose, and sneezing. Further symptoms like fatigue, headache, muscle pains, and decreased appetite are typically reported as well. It's worth mentioning that the once distinctive symptom of loss of smell or taste appears to be less prevalent with Omicron infections.
The Independent
12 hours ago
- The Independent
What is new ‘Stratus' Covid variant? Symptoms as cases grow in UK
A new strain of Covid, with a unique symptom, is circulating in the UK, accounting for a high proportion of cases in England. The new strain, called Stratus, has two variants, XFG and XFG.3, with XFG.3 accounting for 30 per cent of cases in the country. Unlike other strains, some experts have suggested the Stratus variant is known for its unique symptom of giving people a hoarse voice. Despite accounting for a large proportion of new cases, experts are not concerned over the spread, noting it is normal for viruses to mutate and change. 'It is normal for viruses to mutate and change over time,' Dr Alex Allen, consultant epidemiologist of UKHSA said, adding that it continues to monitor all strains of Covid in the UK. What is 'Stratus' XFG and XFG.3? The World Health Organisation has designated the XFG as a 'variant under monitoring' and has said the additional public health risk posed by XFG is evaluated as low at the global level. Globally, XFG was estimated to have the highest relative growth compared to other varients currently circluated, including the recent 'Nimbus' NB.1.8.1. Current data does not indicate that this variant leads to more severe illness or deaths than other variants in circulation, the organisation said. What are the symptoms? While evidence shows an increased proportion of XFG WHO has not observed any signs that it has an increase in severity. 'While there are reported increases in cases and hospitalisations in some of the [South-east Asia Region] countries, which has the highest proportion of XFG, there are no reports to suggest that the associated disease severity is higher as compared to other circulating variants, the WHO said. Dr Allen from the UKHSA also noted: 'Based on the available information so far, there is no evidence to suggest that the XFG and XFG.3 variants cause more severe disease than previous variants, or that the vaccines in current use will be less effective against them.' It comes as new Covid variants continue to spread throughout the country, with Nimbus giving people razor-blade like sore throats last month. Some experts have claimed Stratus can give patients a 'hoarse voice.' What are the risks around XFG? The WHO have designated XFG as a 'low risk' globally. It said: 'XFG is growing rapidly compared to co-circulating variants globally. However, XFG exhibits only marginal additional immune evasion over [other varient] LP.8.1. While there are reported increases in cases and hospitalizations in some of the [South-east Asia Region] countries, which has the highest proportion of XFG, there are no reports to suggest that the associated disease severity is higher as compared to other circulating variants. 'The available evidence on XFG does not suggest additional public health risks relative to the other currently circulating Omicron descendant lineages.' Do the Covid vaccines work against NB.1.8.1? Based on available evidence the WHO said the current approved Covid-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease. The organisation said the current data suggests the risk of vaccine evasion is low, however additional laboratory studies are needed to further assess the risk of antibody escape. However, some experts have warned Stratus could also evade immunity from jabs. 'Unlike other variants, Stratus has certain mutations in the spike protein which could help it evade antibodies developed from prior infections or vaccinations,' Dr Kaywaan Khan, Harley Street GP and founder of Hannah London Clinic told Cosmopolitan UK.
South Wales Guardian
a day ago
- South Wales Guardian
Healthy life expectancy at record low for women in most deprived areas
The inequality gap between men and women has also grown, with those living in better-off parts of England enjoying around two more decades of healthy life. The Covid-19 pandemic, with its increased levels of mortality, is continuing to have an impact on life expectancy estimates, according to the Office for National Statistics (ONS) which published the figures. Females born between 2020 and 2022 in the most deprived areas of England were likely to spend just 65.1% of their lives in good health, compared with 81.5% in the least deprived areas, the ONS found. The estimate for the most deprived areas is the lowest since the time series began in 2013-15, when it stood at 66.3%. For males born in 2020-22, the proportion of life expected to be spent in good health was 70.4% for those in the most deprived areas and 84.5% for those in the least deprived. The figure for males in the most deprived parts of England is broadly unchanged on recent years. The gap in healthy life expectancy between females born in the most and least deprived areas has widened from 19.6 years in 2013-15 to 20.2 years in 2020-22, while for males it has grown from 18.7 to 19.1. Greg Ceely, ONS head of population health monitoring, said: 'The pandemic led to increased mortality, the impact of which is seen in our life expectancy estimates. 'However, not everyone was impacted equally. 'The biggest decline in life expectancy was seen in the most deprived areas. 'Healthy life expectancy also declined, and in England and Wales women in the most deprived areas were expected to spend the lowest proportion of life in 'good' health – the smallest since our records began.' Figures for Wales cannot be compared directly with England, due to different systems of measuring deprivation. But the proportion of life that females born in 2020-22 in the most deprived areas of Wales are likely to spend in good health, 61.5%, is the lowest since those estimates began in 2013-15. The equivalent figure for women born in the least deprived areas is 80.7%. For males in Wales, the proportions were 70.2% for the most deprived areas and 83.6% for the least deprived. Although the latest estimates represent a drop compared with the pre-pandemic period, this does not mean a baby born between 2020 and 2022 will necessarily go on to live a less healthy life. Improvements in mortality rates in the future would lead to increases in life expectancy estimates, the ONS noted.
